Carrier-dependent specificity of antibodies to a conserved peptide determinant of gp120

Vaccine

Volumn 21, Issue 11-12, 2003, Pages 1213-1218

  Karle, S ^a   Nishiyama, Y ^a   Taguchi, H ^a   Zhou, Y X ^a   Luo, J ^a   Planque, S ^a   Hanson, C ^b   Paul, S ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b VIRAL AND RICKETTSIAL DISEASE LABORATORY   (United States)

Author keywords

Antigenic specificity; Gp120; Protein carriers; T epitope

Indexed keywords

ANTIBODY; ANTIGEN; BOVINE SERUM ALBUMIN; CYSTEINE; EPITOPE; GLYCOPROTEIN GP 120; PEPTIDE; TETANUS TOXOID;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; AUTOIMMUNITY; CONJUGATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNITY; IMMUNIZATION; IMMUNOGENICITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN IMMOBILIZATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODY SPECIFICITY; ANTIGENS, CD95; AUTOIMMUNE DISEASES; CATTLE; DRUG CARRIERS; EPITOPES; FEMALE; HEMOCYANIN; HIV ANTIBODIES; HIV ANTIGENS; HIV ENVELOPE PROTEIN GP120; HIV-1; HUMANS; IMMUNIZATION; IMMUNOCONJUGATES; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE; MICE, INBRED BALB C; MICE, INBRED MRL LPR; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; SERUM ALBUMIN, BOVINE; TETANUS TOXOID;

EID: 0037424141     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(02)00504-2     Document Type: Article

References (23)

1. Moore J., Trkola A. HIV type 1 coreceptors, neutralization serotypes, and vaccine development. AIDS Res Hum Retroviruses. 13:1997;733-736.
2. Profy A.T., Salinas P.A., Eckler L.I., Dunlop N.M., Nara P.L., Putney S.D. Epitopes recognized by the neutralizing antibodies of an HIV-1-infected individual. J Immunol. 144:1990;4641-4647.
3. Thali M., Furman C., Ho D.D., Robinson J., Tilley S., Pinter A.et al. Discontinuous, conserved neutralization epitopes overlapping the CD4-binding region of human immunodeficiency virus type 1 gp120 envelope glycoprotein. J Virol. 66:1992;5635-5641.
4. Olshevsky U., Helseth E., Furman C., Li J., Haseltine W., Sodroski J. Identification of individual human immunodeficiency virus type 1 gp120 amino acids important for CD4 receptor binding. J Virol. 64:1990;5701-5707.
5. Kwong PD, Wyatt R, Robinson J, Sweet RW, Sodroski J, Hendrickson WA. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature 1998;393:630-1,48-59.
6. Bukawa H., Sekigawa K.I., Hamajima K., Fukushima J., Yamada Y., Kiyono H.et al. Neutralization of HIV-1 by secretory IgA induced by oral immunization with a new macromolecular multicomponent peptide vaccine candidate. Nat. Med. 1:1995;681-685.
7. Ahlers J.D., Pendleton C.D., Dunlop N., Minassian A., Nara P.L., Berzofsky J.A. Construction of an HIV-1 peptide vaccine containing a multideterminant helper peptide linked to a V3 loop peptide 18 inducing strong neutralizing antibody responses in mice of multiple MHC haplotypes after two immunizations. J Immunol. 150:1993;5647-5665.
8. Fraziano M., Montesano C., Lombardi V.R., Sammarco I., De Pisa F., Mattei M.et al. Epitope specificity of anti-HIV antibodies in human and murine autoimmune diseases. AIDS Res Hum Retroviruses. 12:1996;491-496.
9. Bermas B.L., Petri M., Berzofsky J.A., Waisman A., Shearer G.M., Mozes E. Binding of glycoprotein120 and peptides from the HIV-1 envelope by autoantibodies in mice with experimentally induced systemic lupus erythematosus and in patients with the disease. AIDS Res Hum Retrovir. 10:1994;1071-1077.
10. Morrow W.J., Williams W.M., Whalley A.S., Ryskamp T., Newman R., Kang C.Y.et al. Synthetic peptides from a conserved region of gp120 induce broadly reactive anti-HIV responses. Immunology. 75:1992;557-564.
11. Dyrberg T., Oldstone M.B. Peptides as antigens. Importance of orientation. J Exp Med. 164:1986;1344-1349.
12. Taguchi H, Nishiyama Y, Burr G, Karle S, Paul S. Synthesis of a covalently reactive antigen analog derived from a conserved sequence of HIV-1 gp120. In: Houghten RA, Lebl RA, editors. Proceedings of the 2nd International and 17th American Peptide Symposium. San Diego: American Peptide Society; 2002. p. 1033-4.
13. Panina-Bordignon P., Tan A., Termijtelen A., Demotz S., Corradin G., Lanzavecchia A. Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells. Eur J Immunol. 19:1989;2237-2242.
14. Fujiwara K., Yasuno M., Kitagawa T. Novel preparation method of immunogen for hydrophobic hapten, enzyme immunoassay for daunomycin and adriamycin. J Immunol Methods. 45:1981;195-203.
15. Ellman G.L. Tissue sulfhydryl groups. Arch Biochem Biophys. 82:1959;70-77.
16. Kalaga R., Li L., O'Dell J., Paul S. Unexpected presence of polyreactive catalytic antibodies in IgG from unimmunized donors and decreased levels in rheumatoid arthritis. J Immunol. 155:1995;2695-2702.
17. Mozes E., Schwartz M., Sela M. Antibody responses of inbred mouse strains to ordered tetrapeptides of tyrosine and glutamic acid attached to multichain polyalanine or polyproline. J Exp Med. 140:1974;349-355.
18. Gololobov G., Noda Y., Sherman S., Rubinstein I., Baranowska-Kortylewicz J., Paul S. Stabilization of vasoactive intestinal peptide by lipids. J Pharmacol Exp Ther. 285:1998;753-758.
19. Griffin J.F., Smith G.D. X-ray diffraction studies of enkephalins and opiates. NIDA Res Monogr. 87:1988;41-59.
20. Rini J.M., Schulze-Gahmen U., Wilson I.A. Structural evidence for induced fit as a mechanism for antibody-antigen recognition. Science. 255:1992;959-965.
21. Sun N.C., Ho D.D., Sun C.R., Liou R.S., Gordon W., Fung M.S.et al. Generation and characterization of monoclonal antibodies to the putative CD4-binding domain of human immunodeficiency virus type 1 gp120. J Virol. 63:1989;3579-3585.
22. Clerget-Raslain B., Benjouad B., Van Rietschoten J., Montagnier L., Rochat H., Bahraoui E. Specificity of anti-peptide antibodies elicited against synthetic peptides mimicking conserved regions of HIV 1 envelope glycoprotein. Res Virol. 142:1991;423-438.
23. Ardman B., Kowalski M., Bristol J., Haseltine W., Sodroski J. Effects on CD4 binding of anti-peptide sera to the fourth and fifth conserved domains of HIV-1 gp120. J Acquir Immune Defic Syndr. 3:1990;206-214.